Trials / Completed
CompletedNCT04351893
Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 935 (actual)
- Sponsor
- Seattle Children's Hospital · Academic / Other
- Sex
- All
- Age
- 0 Years – 18 Years
- Healthy volunteers
- —
Summary
The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.
Conditions
- Microtia
- Microtia-Anotia
- Craniofacial Microsomia
- Goldenhar Syndrome
- OAVS
- OAV Syndrome
- Hemifacial Microsomia
Timeline
- Start date
- 2018-02-23
- Primary completion
- 2021-11-30
- Completion
- 2023-08-30
- First posted
- 2020-04-17
- Last updated
- 2024-04-22
Locations
10 sites across 4 countries: United States, Colombia, Peru, Spain
Source: ClinicalTrials.gov record NCT04351893. Inclusion in this directory is not an endorsement.